BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2460 related articles for article (PubMed ID: 25448878)

  • 1. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
    Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
    Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial VDAC1: function in cell life and death and a target for cancer therapy.
    Shoshan-Barmatz V; Golan M
    Curr Med Chem; 2012; 19(5):714-35. PubMed ID: 22204343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress.
    Shoshan-Barmatz V; Maldonado EN; Krelin Y
    Cell Stress; 2017 Oct; 1(1):11-36. PubMed ID: 30542671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDAC1: from structure to cancer therapy.
    Shoshan-Barmatz V; Mizrachi D
    Front Oncol; 2012; 2():164. PubMed ID: 23233904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
    Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
    Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VDAC1 functions in Ca
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
    Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
    Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins.
    Abu-Hamad S; Arbel N; Calo D; Arzoine L; Israelson A; Keinan N; Ben-Romano R; Friedman O; Shoshan-Barmatz V
    J Cell Sci; 2009 Jun; 122(Pt 11):1906-16. PubMed ID: 19461077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
    Shoshan-Barmatz V; Mizrachi D; Keinan N
    Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
    Front Oncol; 2017; 7():154. PubMed ID: 28824871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
    Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
    J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An N-terminal nucleotide-binding site in VDAC1: involvement in regulating mitochondrial function.
    Yehezkel G; Abu-Hamad S; Shoshan-Barmatz V
    J Cell Physiol; 2007 Aug; 212(2):551-61. PubMed ID: 17503466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VDAC1 cysteine residues: topology and function in channel activity and apoptosis.
    Aram L; Geula S; Arbel N; Shoshan-Barmatz V
    Biochem J; 2010 Apr; 427(3):445-54. PubMed ID: 20192921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
    Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding.
    Abu-Hamad S; Zaid H; Israelson A; Nahon E; Shoshan-Barmatz V
    J Biol Chem; 2008 May; 283(19):13482-90. PubMed ID: 18308720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.
    Ben-Hail D; Begas-Shvartz R; Shalev M; Shteinfer-Kuzmine A; Gruzman A; Reina S; De Pinto V; Shoshan-Barmatz V
    J Biol Chem; 2016 Nov; 291(48):24986-25003. PubMed ID: 27738100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 123.